CONTEXT: We aim to bring you all the news surrounding Real World Research and sometimes our team of electronic gnomes turn up a story like this – hence the Schrödinger’s Continue Reading
CONTEXT: Commercial announcement relating to decentralised clinical trial capabilities IMPACT: Low READ TIME: 1 min 1. “SCOTTSDALE, Ariz., March 9, 2021 /PRNewswire/ — VirTrial, the leading provider of telemedicine technology, Continue Reading
CONTEXT: Peer reviewed (although only one person who wasn’t going to own up to it) paper from Clinical Ophthalmology journal on patient satisfaction in glaucoma treatments. IMPACT: Low READ TIME: Continue Reading
CONTEXT: This is why we love RWR. To see a treatment option being approved by the FDA off the back of RWD that had already been collected to improve the Continue Reading
CONTEXT: An interesting article highlighting the FDA’s position on RWR in the rapidly developing field of AI within SaMD. Within the proposed FDA framework, in the post-marketing realm, quote “the Continue Reading
CONTEXT: Small retrospective study on a biologic treatment for Psoriasis. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 7 1. “A real-world study suggests guselkumab is Continue Reading
CONTEXT: Machine learning algorithms and large RWD data sets combining to look for “new” indications for existing compounds. Make the most of what you’ve got is certainly a very cost Continue Reading
CONTEXT: Commercial announcement of another company acquiring RWE data assets | Patient search and identification meets data aggregation to produce de-identified, enriched, longitudinal data points derived from complex medical data Continue Reading
CONTEXT: Ordinarily we wouldn’t post news about RCT studies. However, the thing that caught our eye in this article is the need to point out that the research question they Continue Reading
CONTEXT: Peer reviewed retrospective study of a triple oral combination therapy in PAH | Japan only data. IMPACT: medium READ TIME: 2 mins Quality Level Mean [1 – 10]: 8 Continue Reading
